LATEST TWEETS - CURATED BY HASH FINANCE

$KMDA stock is up 3.73 % with an ok PE 11.86 and beta 0.20 https://t.co/Xc9aONH5Re
Kamada $KMDA Share Price Crosses Above 50 Day Moving Average of $5.98 https://t.co/t7r4KBbqDs
$KMDA the steal of the night imo https://t.co/XOyXyXcxvQ
Kamada $KMDA Enters into a Binding Term Sheet for Contract Manufacturing of an FDA Approved, Commercialized Hyper-I… https://t.co/c4bFmPk3l1
$KMDA Kamada Enters into a Binding Term Sheet for Contract Manufacturing of an FDA Approved, Commercialized Hyper-I… https://t.co/nPcNV5mr8n
stck.pro (StckPro) 1 day ago
$KMDA NEW ARTICLE : Kamada inks binding term sheet for hyper-immune globulin product https://t.co/6T3vycJlYF
$KMDA Kamada Enters into a Binding Term Sheet for Contract Manufacturing of an FDA Approved, Commercialized https://t.co/tmbEgoowsX
Israel-based Kamada Ltd announced this week that it has entered into an agreement with Iceland-based Alvotech to co… https://t.co/AovvdAVaGB
$0.16 Earnings Per Share Expected for Kamada Ltd. $KMDA This Quarter https://t.co/DPsmoITOBd
$KMDA weekly resting. Would love to add in the $6's https://t.co/wR9R7zamvX
$KMDA auction is now open. -4.45 % change recently https://t.co/Xc9aONH5Re
Fintel.io (fintel_io) 1 week ago
Brosh Capital Partners L.p. has filed an amended 13D/A, reporting 6.0% ownership in $KMDA - https://t.co/ARMq06k8zr
Kamada in pact with Alvotech to commercialization 6 biosimilars in Israel $KMDA https://t.co/KI7VvpHZji
$KMDA Kamada Enters into Partnership with Alvotech for Commercialization of Six Biosimilar Products in Israel https://t.co/3AzJ2OWTFA
$KMDA - Kamada inks deal with Alvotech for commercialization of six biosimilar products in Israel https://t.co/vU1HTd8DSn
Did Hedge Funds Drop The Ball On Kamada Ltd (KMDA) ? https://t.co/zlzoFDVYTZ #YahooFinance #Traffic #Transportation… https://t.co/FBRcnbrwko
$KMDA Kamada Enters into Partnership with Alvotech for Commercialization of Six Biosimilar Products in Israel https://t.co/bj1fnt0dy5
Kamada Enters into Partnership with Alvotech for Commercialization of Six Biosimilar Products in Israel: REHOVOT Is… https://t.co/pnHWSAiJvN
$KMDA: Kamada Enters into Partnership with Alvotech for Commercialization of Six Biosimilar Products in Israel
$0.16 EPS Expected for Kamada Ltd. $KMDA This Quarter https://t.co/UwqsBolPVb